Vyvanse Recall 2025: What’s Been Pulled, Who’s Affected, and What to Do Now

Bassyonni

ago 2 hours

Vyvanse Recall 2025

A nationwide recall of several lots of lisdexamfetamine dimesylate capsules—the generic version of Vyvanse—is underway after the medication failed dissolution tests in the lab. The issue: certain capsules may not dissolve properly, which can reduce effectiveness in the body. The recall was initiated October 28, 2025 and categorized as a Class II recall on October 30, meaning the risk of serious harm is considered remote, but temporary or medically reversible effects are possible.

What exactly is being recalled?

Product: Lisdexamfetamine dimesylate capsules (generic Vyvanse), multiple strengths
Dosages noted in recall coverage: 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, 70 mg
Packaging: Typically 100-count bottles
Timeline: Affected lots were shipped May–November 2024 with expiration dates in 2026
Reason: Failed dissolution specifications (capsules may not release medicine as intended)
Risk level: Class II (low likelihood of serious injury; potential for reduced effect or reversible issues)

Important: The recall targets specific lots of the generic capsules. It does not include brand-name Vyvanse unless separately stated. Always verify your bottle’s details.

How to check if your medication is part of the recall

Locate your bottle and find the drug name, strength, NDC number, and lot number (often near the barcode or on the side panel).
Call your pharmacy: Ask them to confirm the lot against the current recall notice and advise next steps.
If affected, your pharmacist can arrange replacement and explain how to return or dispose of the recalled bottle per store policy.
If you use pill organizers, keep the original bottle until you’ve verified the lot.

Should you stop taking it?

Do not stop abruptly without medical guidance. A sudden stop can trigger rebound symptoms (e.g., fatigue, mood changes, reduced focus). Instead:

Continue as prescribed until you speak with your prescriber or pharmacist.
If you feel your current capsules are not working as usual (shorter effect, inconsistent focus), document what you notice—time taken, duration of effect, side effects—and share that with your clinician.
Ask about switching to an unaffected lot, another manufacturer, or brand-name Vyvanse if appropriate for your insurance and availability.

Why “failed dissolution” matters

For capsules, dissolution determines how quickly and completely the drug releases and absorbs. If it under-performs, you might experience:

Reduced or inconsistent symptom control
Unusual timing (e.g., effect wearing off too soon)
Dose-adjustment confusion if the problem is the capsule, not your regimen

The recall’s Class II status reflects that while serious harm is unlikely, suboptimal therapy can still affect daily functioning, school/work performance, driving, and overall quality of life.

What if you’re a parent or caregiver?

Check every bottle in the home, backpack, or school nurse’s office.
Notify teachers/coaches if you suspect a control issue so they can watch for concentration or behavior shifts.
Coordinate refills early—supply can be tight, and pharmacies may need to source unaffected lots or alternative strengths.

Insurance and supply tips

Pharmacies can reprocess claims for replacements tied to a recall; coverage varies.
If your store is out of unaffected stock, ask them to transfer the prescription to a location that has it.
If you must switch manufacturers or to brand, request your prescriber include “dispense as written” only when necessary, since that can affect flexibility during shortages.

Key reminders at a glance

What’s recalled? Selected lots of generic lisdexamfetamine capsules.
Why? Dissolution failure → possible reduced effectiveness.
Risk level? Class II (low risk of severe harm; reversible effects possible).
Stop now? No—talk to your prescriber/pharmacist first.
Brand name included? No, the recall targets generic capsules (unless specifically noted).
Next step? Check your lot number and contact your pharmacy for verification and replacement guidance.

If you rely on lisdexamfetamine for ADHD management, treat this as a quality control issue, not a cause for panic. With your pharmacist’s help, you can confirm lot status, secure an unaffected supply, and keep your treatment consistent and effective.